Chimeric Antigen Receptors for T-Cell Malignancies

Our approaches combine biological and engineering insights to enable target-unlock without the risk and complexity of additional gene editing. March Biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies for challenging indications across hematological cancers.

This is test copy as an example of content length. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.